Clinical Trial Update: Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cyclophosphamide and hydroxychloroquine for thrombocytopenia in systemic lupus erythematosus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus
• Thrombocytopenia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Chinese SLE Treatment And Research Group | Conditions: Thrombocytopenia | Phase 3 | Status: TERMINATED